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1146Objective: Surgical ablation for the treatment of atrial fibrillation is now being performed routinely in centers
throughout the world. After the hospital stay, patients’ care is usually delivered by cardiologists who are often
unfamiliar with the nuances of the procedure, as well as the management of patients’ medical regimens and atrial
arrhythmia recurrence. We sought to determine the effectiveness of a postdischarge protocol designed not only to
capture patients’ rhythm status but also to coordinate their clinical management when required for all patients
undergoing surgical ablation in our institution.
Methods: A unique, computer-based atrial fibrillation registry was developed to comply with the Heart Rhythm
Society guidelines. An extensive follow-up program to track patients’ preoperative characteristics and operative
and postoperative courses was established. The required long-term clinical follow-up and interventions were
based on a simple clinical algorithm-driven protocol that was developed and recommended by us to be used.
All available patients were followed at each respective time point and were evaluated for protocol implementation
as determined by the algorithm. Stepwise logistic regression was used to determine whether being on the protocol
was a significant predictor for being in sinus rhythm at 18 and 24 months.
Results: At the time of the study, we had 391 patients (multiple surgeons) in our registry with more than 2000
clinical records and follow-up rhythm status information. Overall, the return to sinus rhythm was 88%, 87%, and
84% at 6, 12, and 24 months, respectively. Significantly higher rates of sinus rhythm were documented for pa-
tients whose care was managed according to the algorithm, with a return to sinus rhythm rate of 92% versus 72%,
91% versus 62%, and 89% versus 40% at 6, 12, and 24 months, respectively. Fifty-one percent of the patients in
atrial fibrillation at 12 months did not receive treatment as indicated by the algorithm, with the most common de-
viations being a change in antiarrhythmic drug treatment, any attempt of cardioversion, and premature placement
of patients on a rate-control regimen. The odds of being in sinus rhythm at 24 months was significantly increased
when a patient’s care was managed according to the protocol (on protocol: odds ratio, 8.066; 95% confidence
interval, 1.085–59.940; P ¼ .041).
Conclusion: This study describes a new concept in which a clinical algorithm is being used to manage patients
after surgical ablation. Our findings suggest that the success rate of the surgical ablation procedure was signifi-
cantly better in patients who were followed and treated according to the clinical algorithm. These findings suggest
that coordination of patients’ treatment with cardiologists is challenging but essential to enhance the long-term
success rate of the surgical ablation procedure. (J Thorac Cardiovasc Surg 2010;139:1146-52)The Cox maze III procedure is a well-established approach
and offers patients with medical refractory atrial fibrillation
(AF) an alternative treatment option.1-8 However, the advent
of this surgical intervention also requires clinicians to
develop an understanding of the unique, long-term medical
care issues required to determine a successful outcome. In
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The Journal of Thoracic and Cardiovascular SurRhythm Association, and the European Cardiac Arrhythmia
Society, developed a consensus statement on catheter and
surgical ablation of AF.9 The purpose of the consensus state-
ment was to provide recommendations for ablation pro-
grams that included: (1) guidelines for personnel training,
(2) patient selection criteria, and (3) necessary components
of a follow-up program to determine the success of the abla-
tion program.
The guidelines are also unique in recommending the nec-
essary components for follow-up after an ablation to include
the following: (1) the importance of follow-up for patients
every 6 months for at least 2 years after the initial follow-
up at 3 months after ablation; (2) use of an event monitor
to screen for recurrent AF/atrial tachycardia/atrial flutter in
patients complaining of palpitations; (3) discontinuation of
warfarin only after patients had some type of continuous
monitoring to screen for asymptomatic AF/atrial tachycardia
or atrial flutter; (4) avoidance of a repeat procedure for atgery c May 2010
Abbreviations and Acronyms
AF ¼ atrial fibrillation
ECG ¼ electrocardiography
SR ¼ sinus rhythm
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medical therapy; and (5) definition of success being no mon-
itored atrial arrhythmia of greater than 30 seconds while off
antiarrhythmic drugs. Although these guidelines have
provided a very good beginning as to how to follow patients
after an ablation, they lack clear details on what to do when
patients are experiencing problems after an ablation, as well
as how to address patients who are doing well in regard to
the timing of stopping antiarrhythmic drugs and possibly an-
ticoagulation therapy. These nuances of care are especially
lacking when caring for a patient after the Cox maze proce-
dure, despite the fact that the surgical ablation to treat AF is
now performed routinely.
We always believed that a follow-up program to focus
only on rhythm and disregarding the clinical approach might
be limited. After the first assessment of the postdischarge
clinical data from our initial 142 patients undergoing opera-
tions during 2005–2006, it was clear to us that a clinical
algorithm-driven protocol was required to improve our un-
derstanding and delivery of care. The first assessment demon-
strated that of the 119 patients who had the surgical ablation
procedure either as a stand-alone procedure or combined with
other cardiac surgical interventions and at least 3 months’
follow-up information, normal sinus rhythm (SR) was docu-
mented in 108 (91%). AF or atrial flutter was documented in
the other 11 (9%) patients. To our surprise, 44 (40%) of the
patients in SR were found to be managed pharmacologically
with antiarrhythmic drugs we believed were unnecessary. For
the 11 patients who remained in AF/atrial flutter, only 3
(27%) were followed with any antiarrhythmic protocol
with regard to modification of their antiarrhythmic drug ther-
apy, as well as consideration for electrical cardioversion.
Our initial assessment clearly demonstrated that an
acceptable outcome could be anticipated after the surgical
ablation procedure. However, we determined that a compre-
hensive postdischarge protocol was necessary to better
address recurrence of atrial arrhythmias and reduce the use
of antiarrhythmic drugs and warfarin after SR was restored.
Our thought was that the written protocol would also provide
a means of collaboration between cardiologists and surgeons
after ablation surgery for this selected group of patients. The
purpose of this study was to describe and perform an initial
assessment of whether such a protocol can be implemented
in a community-based hospital and whether such a postdi-
scharge protocol is effective in enhancing the success rate
of the surgical ablation procedure.The Journal of Thoracic and CarMATERIALS AND METHODS
The follow-up programwas adjusted in October 2006 and then refined in
May 2007 to adhere to the Heart Rhythm Society guidelines.9 The forumwe
currently use is a unique AF registry operated through a statistical platform
that interacts with and compliments the Society of Thoracic Surgeons data-
base (Figure 1). The AF registry tracks all patients’ preoperative, operative,
and postoperative characteristics not captured in the Society of Thoracic
Surgeons database, as well as patients’ health-related quality of life (the
SF-12 health survey).10 Clinical information and patients’ algorithm-
driven protocol status is used as a mechanism for comprehensive interpre-
tation of the clinical data, as well as a forum to communicate our recommen-
dations to the respective cardiologists. Our current clinical structure is that
all our institution’s cardiologists are part of private practices, and therefore
we did not randomize patients. Rather, we conducted this study to determine
the initial effect of a clinically driven algorithm on patients’ outcomes in
a real-world scenario in a large community hospital.
All patients who underwent a Cox maze procedure or other surgical ab-
lation with either cryothermal energy alone or in combination with bipolar
radiofrequency were entered into our AF registry. Subsequent clinical status
information and health-related quality of life data were then obtained at 3, 6,
12, and 24 months after surgical intervention and then yearly thereafter. The
clinical information collected included (1) patients’ self-reported rhythm,
(2) current medications, (3) any readmissions and cardiac intervention
that had taken place during the interim, and (4) the date of the last visit to
the cardiologist. Diagnostic (electrocardiography [ECG], Holter monitor-
ing, 1-week monitoring, or pacemaker interrogation) rhythm information
was obtained from the patients’ last visit to their cardiologists to assist in de-
termining the patients’ current rhythm (Figure 2).
The algorithm/protocol used to interpret and guide our follow-up program
was developed through a compilation of the literature and interviews with
experts in the field (Figure 3).11-17 The protocol recommends that all patients
be discharged and maintained on an arrhythmic drug, such as amiodarone or
sotalol, during the first 3 months after the operation (the blanking period).
Patients are also started on warfarin regardless of their rhythm at discharge
because their rhythm might be unstable for the first 3 months after the
operation.9,18-20 After the blanking period, all patients are recommended to
undergo 12-lead ECG, 24-hour Holter monitoring, or both to confirm their
current rhythm status. If the patients’ ECG/Holter monitoring results
demonstrate SR, the discontinuation of the patients’ antiarrhythmic drug is
recommended, but warfarin is continued.1,18-20 Approximately 4 to 12 weeks
(depending on the antiarrhythmic drug taken) after the discontinuation of
patients’ antiarrhythmic drug, the patients should undergo at least 5 days of
rhythm monitoring to determine their respective rhythm without
antiarrhythmic drugs. This is to ensure that patients are not experiencing any
silent episodes of clinically significant AF (>30 seconds).9 At this time, if
the results of the long-term monitoring demonstrate SR and the left atrial ap-
pendage is confirmed to be not communicating after it was surgically excluded
or amputated, we recommend re-evaluation for the continuation of warfarin.
Patientswith no indication for the continuation ofwarfarin are started on aspirin
postoperatively.
For patients who are still experiencing AF 4 to 6 weeks after surgical ab-
lation, the patient should be evaluated for cardioversion according to the
standard guidelines for cardioversion.21 The use of a different antiarrhyth-
mic drug should also be considered at this time.
This pattern of intervention was used at each patient’s follow-up visit ev-
ery 3 months for at least the first year (Figure 3). Starting the patient on rate-
control medication after the surgical ablation procedurewas only considered
after attempting cardioversion 3 times and the use of several different anti-
arrhythmic drugs without successful conversion of the patient’s AF rhythm
to SR. A letter was sent to the patients’ cardiologists after the patients’
follow-up surgical visits to assist in the collaborative relationship between
the cardiac surgeon and the cardiologist. The letter had specific recommen-
dations for the patients’ follow-up care, irrespective of whether the patient
was in SR or AF. A follow-on letter with protocol-driven recommendationsdiovascular Surgery c Volume 139, Number 5 1147
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FIGURE 1. Picture of the registry process. STS, Society of Thoracic Surgeons.
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a patient was not following the protocol during our clinical follow-up.
Descriptive statistics and frequencies were used to describe the patients
and SR by time point. Mantel–Haenszel c2 tests were used to determine
whether there were differences in SR rates at 6 and 12 months by surgical
group. To determine whether the algorithm-driven protocol had an effect
on the outcome of SR at 24 months, we divided the patients into 2 groups:
those patients who were on the protocol at their 6-, 12-, and 18-month
follow-up time points (on-protocol group) versus all others (off-protocol
group). A multiple logistic regression model was then constructed. In the first
step of the model, we entered the type of surgical ablation (Cox maze
procedure vs limited left atrial ablation) and variables known to be associated
with the development of AF after the surgical ablation procedure, which
were age, duration of AF before the surgical intervention, and left atrial
size. Duration and type of AF were highly associated, and therefore only
duration was selected to be a part of the model. In the second step we entered
the newly formed protocol status variable (on-protocol group vs off-protocol
group). All analysis was completed with SAS version 9.1.3 software (SAS
Institute, Inc, Cary, NC) and SPSS version 17 (SPSS, Inc, Chicago, Ill).
RESULTS
Since our program inception in 2005, 391 patients have
undergone surgical ablation procedures performed by multi-
ple surgeons at our institute. The average time to follow-up1148 The Journal of Thoracic and Cardiovascular Surwas 29.42 16.27 months. Three hundred forty-two (87%)
patients underwent the Cox maze procedure with or without
concomitant surgical intervention; 49 (13%) patients under-
went a left-sided ablation only with concomitant surgical
intervention. The patients’ average age was 63.3  12.1
years, with an average time from first diagnosis of onset of
AF of 42  57.8 months.
The return to SR at 6, 12, 18, and 24months for all patients
(overall) was 88%, 87%, 82%, and 84%, respectively.
There were no significant differences between surgical (full
maze procedure vs left-sided ablation) groups on the return
to SR at these respective time points (P> .05); however,
left-sided ablation only was found to be an independent pre-
dictor for failure (Table 1), and this fact is well established in
the literature.22 Of note, patients on the protocol maintained
a fairly constant rate of SR, whereas patients off the protocol
did not (Figure 4). There was a significant difference between
patients in SR and those experiencing AF occurrences in the
duration of AF before the surgical intervention. Patients expe-
riencing recurrence of atrial arrhythmia at 12months (n¼ 25)
had a significantly longer duration of AF before the operationgery c May 2010
FIGURE 2. Post–surgical ablation follow-up. D/C, Discharge; F/U, follow-up.
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(n ¼ 180; 94.46  88.89 vs 37.51  51.1 months;
P ¼ .0042). Significantly higher and stable rates of SR
were documented for patients whose follow-up carewasman-
aged according to the algorithm, with a return to SR rate of
92% versus 72%, 91% versus 62%, and 89% versus
40% at 6, 12, and 24 months, respectively (Figure 4).
Patients included in logistic regression who were off the
protocol at 24 months (n¼ 40) were older and had a slightly
higher prevalence of mild chronic lung disease than patients
in the on-protocol group (n ¼ 54). However, there were no
differences between these groups in the other known vari-
ables associated with AF: left atrial size and type of AF.
There was also no difference between groups for the type
of surgical ablation performed (Table 2).
When assessing outcome at 24 months, logistic regression
analysis pointed out that implementation of the clinical pro-
tocol was the most significant predictor of return to SR at 24
months (Table 1). Those on the protocol at 6, 12, and 18
months had more than 8 times the odds of being in SR as
those not on the protocol at 6, 12, and 18 months (point es-
timate, 8.44; 95% confidence interval, 1.72–41.49) afterThe Journal of Thoracic and Carcontrolling for the type of maze procedure and variables
known to be associated with return to AF (Table 2). Left
atrial size and type of maze procedure were also found to
be significant predictors, with patients with greater left atrial
size and those undergoing the type IB maze procedure hav-
ing decreased odds of being in SR.
We also determined that 51% of the patients who re-
mained in AF and considered a ‘‘failure’’ by their cardiolo-
gist did not complete the protocol we had recommended.
The most common deviations noted at the patients’ last
known follow-up included no change in antiarrhythmic
drug treatment, no attempt at cardioversion, and prematurely
starting the patients on a rate-control regimen.
In addition, we noted that our follow-up system has gen-
erated more than 2000 clinical follow-up records, as well as
334 letters on behalf of 230 patients. With our follow-up sys-
tem, we have also been able to identify the number and type
of interventions that have been required to obtain and main-
tain SR after the Cox maze procedure. We have observed
that 67 (18%) patients have required 107 cardioversions;
14 (4%) patients have required an ablation after the surgical
ablation procedure, most commonly for atrial tachycardia;diovascular Surgery c Volume 139, Number 5 1149
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FIGURE 3. The clinical algorithm for patients after surgical ablation. AAD, Antiarrhythmic drug; ECG, electrocardiography; ASA, aspirin.
TABLE 1. Logistic regression to determine the effect of the protocol
on the odds of being in sinus rhythm at 24 months (n ¼ 94; on
protocol: 49 vs no protocol: 36)
Point estimate 95% CI df P value
Age 0.936 0.870–1.006 1 .073
Left atrial size 0.375 0.158–0.890 1 .026
Duration of atrial fibrillation 0.991 0.981–1.001 1 .068
Full Cox maze procedure 8.066 1.085–59.940 1 .041
On-protocol group 8.443 1.718–41.485 1 .009
2 Log likelihood ¼ 56.031; Hosmer and Lemeshow goodness of fit c2 ¼ 6.649;
P ¼ .466. CI, Confidence interval; df, degree of freedom.
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intervention; and 37 (10%) patients have had at least 1
change of their antiarrhythmic drug. We have also seen the
percentage of patients reported to be in normal SR main-
tained on antiarrhythmic drugs unnecessarily change over
time, where at 6 months only 10% of patients were still tak-
ing what appeared to be unnecessary antiarrhythmic drugs to
only 4% at 24 months.
DISCUSSION
The surgical treatment for AF is now a well-established
surgical procedure that is being performed routinely. Despite
the fact that it is performed routinely, there is a lack of stan-
dardization concerning the lesion set and the ablative de-
vices in use. It is also clear from our work that there are
no directions for the post–surgical ablation treatment
follow-up that might be necessary for patients to maintain1150 The Journal of Thoracic and Cardiovascular SurSR. Patients are being followed differently and in different
institutes after surgical intervention. In some cases surgeons
are following patients, and in others cardiologists are follow-
ing them. What was clear with our patients is that even in
patients undergoing operations in the same institute, manygery c May 2010
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TABLE 2. Demographic and clinical characteristics of patients on
versus off the clinical protocol at 24 months postoperatively
On protocol
(n ¼ 54)
Off protocol
(n ¼ 40)
Age (y)* 61.2  11.3 66.2  12.9
Female sex 14 (26%) 15 (38%)
Length of stay (d)y 6.4  3.7 10.4  7.8
AF type (m)
Paroxysmal 1 1
Persistent 18 18
Longstanding 32 20
Left atrial size (cm) 4.9  0.9 4.8  0.9
Type of ablation
Cox maze procedure 48 35
Limited left-sided ablation 6 5
Mild chronic lung disease* 0 5
AF, Atrial fibrillation. *P< .05. yP< .01.
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used after discharge. The deviations from the protocol might
be considered trivial because the majority involved a lack of
change of antiarrhythmic drugs or DC cardioversion. How-
ever, for the first time, we were able to show that protocol-
guided follow-up at different time points results in a signifi-
cantly higher success rate after surgical ablation.
As our program has continued to evolve, we also noted
that patients were not consistently receiving any type of
long-term monitoring during the initial 6 months. Based
on these findings, we have developed a long-term monitor-
ing program in which all patients reporting SR and off their
antiarrhythmic drug for at least 6 to 10 weeks are started on
a 5-day long-termmonitor. The monitor we currently use has
the ability to quantify, if present, the patients’ AF burden.
Currently, 110 patients have undergone long-term monitor-
ing through our program. These results are sent to the cardi-
ologist along with a letter with any recommendations that we
might have, which continues to enhance our collaborativeThe Journal of Thoracic and Carpractice environment between surgeons and cardiologists
and provide optimal care to the patients.
The data collected in this study have demonstrated that
patients who undergo the Cox maze procedure or other
surgical ablation obtained excellent outcomes. However,
the addition of a clear institutional clinical protocol has
provided the ability to have a comprehensive interpretation
of the data collected. We have to be aware, however, of
the potential effect of certain variables and how a patient’s
rhythm is related to different aspects of compliance with
the protocol, particularly antiarrhythmic drugs and DC car-
dioversion. In contrast, he or she might have been started
on rate control too soon, not allowing for the full effect of
the protocol to be assessed. Thus exposure to the risk of non-
compliance is 2 to 3 times higher in the non-SR patients, and
this, rather than the protocol, might have made it appear that
noncompliance is ‘‘causing’’ recurrence of AF. Therefore
our study is limited by the inability to address the potential
effect of the type of deviation from protocol; however, this
was not the intent of the study. We attempted to establish
a follow-up protocol that is reproducible and results in a stan-
dardized approach in a community-based hospital. Since the
program has been in place, our ability to address the poten-
tial effect of a specific deviation from the protocol on rhythm
is growing with the increased number of patients enrolled,
and this should serve as the basis for a future study and
publication.
The protocol has also assisted in the development of a col-
laborative effort between cardiologists and cardiac surgeons
after ablation surgery to optimize patients’ outcomes and re-
turn to SR. Taken together, these efforts have translated into
greater return to or maintenance of SR for all patients.CONCLUSION
This article summarizes the implementation of a new con-
cept of longitudinal follow-up for patients after surgicaldiovascular Surgery c Volume 139, Number 5 1151
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We determined that the success of surgical ablation is signif-
icantly better in patients who were treated according to our
algorithm-driven protocol. Our protocol provided the ability
for us to determine the success of the operation, as well as
the intended and unintended consequences of cardiac
surgery. The protocol also allowed a true collaborative effort
between cardiologists and surgeons after ablation surgery in
which these collaborative efforts have translated into
a greater return to or maintenance of SR for all patients after
the procedure. Therefore it is imperative for programs that
offer the surgical ablation procedure to have a follow-up
system in place to optimize patients’ outcomes and enhance
collaboration between surgeons and cardiologists.
We thank Sari Holmes, PhD, for her insight and assistance in
further developing this manuscript.
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